miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
Qingyong Chen(117th Hospital of People's Liberation Army), Wei Lu(Central South University)
Cited by 101
Related Papers
MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway
|Oncotarget|2016|116
Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer’s Disease
|The Tohoku Journal of Experimental Medicine|2017|100